ECSP078024A - Inhibidores de la adenilato ciclasa soluble - Google Patents

Inhibidores de la adenilato ciclasa soluble

Info

Publication number
ECSP078024A
ECSP078024A EC2007008024A ECSP078024A ECSP078024A EC SP078024 A ECSP078024 A EC SP078024A EC 2007008024 A EC2007008024 A EC 2007008024A EC SP078024 A ECSP078024 A EC SP078024A EC SP078024 A ECSP078024 A EC SP078024A
Authority
EC
Ecuador
Prior art keywords
adenylate
cycling
inhibitors
soluble
medicament
Prior art date
Application number
EC2007008024A
Other languages
English (en)
Inventor
Duy Nguyen
Bernd Buchmann
Martin Fritsch
Ulf Boemer
Bernd Menzenbach
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ECSP078024A publication Critical patent/ECSP078024A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención se relaciona con compuestos de la fórmula general (I), y con su preparación y su uso como medicamento.
EC2007008024A 2005-06-08 2007-12-17 Inhibidores de la adenilato ciclasa soluble ECSP078024A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005027274A DE102005027274A1 (de) 2005-06-08 2005-06-08 Inhibitoren der löslichen Adenylatzyklase

Publications (1)

Publication Number Publication Date
ECSP078024A true ECSP078024A (es) 2008-01-23

Family

ID=37398540

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007008024A ECSP078024A (es) 2005-06-08 2007-12-17 Inhibidores de la adenilato ciclasa soluble

Country Status (23)

Country Link
EP (1) EP1888058B1 (es)
JP (1) JP2008542422A (es)
KR (1) KR20080016617A (es)
CN (1) CN101193631A (es)
AR (1) AR054378A1 (es)
AT (1) ATE431736T1 (es)
AU (1) AU2006256857A1 (es)
BR (1) BRPI0610934A2 (es)
CA (1) CA2606692A1 (es)
CR (1) CR9578A (es)
DE (2) DE102005027274A1 (es)
DO (1) DOP2006000130A (es)
EA (1) EA200702590A1 (es)
EC (1) ECSP078024A (es)
GT (1) GT200600244A (es)
IL (1) IL186914A0 (es)
MX (1) MX2007015493A (es)
NO (1) NO20080104L (es)
PE (1) PE20061488A1 (es)
TW (1) TW200716090A (es)
UY (1) UY29583A1 (es)
WO (1) WO2006131398A2 (es)
ZA (1) ZA200800153B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006014319B4 (de) * 2006-03-23 2009-01-08 Bayer Schering Pharma Aktiengesellschaft Inhibitoren der löslichen Adenylatzyklase
EP2036906A1 (de) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindole als Inhibitoren der löslichen Adenylatzyklase
WO2023100061A1 (en) 2021-12-01 2023-06-08 Pfizer Inc. 3-phenyl-1-benzothiophene-2-carboxylic acid derivatives as branched-chain alpha keto acid dehydrogenase kinase inhibitors for the treatment of diabetes, kidney diseases, nash and heart failure

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2635776B1 (fr) * 1988-09-01 1993-06-11 Rhone Poulenc Agrochimie Derives amides, procede pour leur fabrication et compositions fongicides les contenant
US20020064849A1 (en) * 2000-09-05 2002-05-30 Herr John C. Human soluble testicular adenylyl cyclase
EP1404653B1 (en) * 2001-06-28 2008-08-20 Pfizer Products Inc. Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
CA2465978C (en) * 2001-09-14 2015-04-07 Soon Hyung Woo Inhibitors of histone deacetylase
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
US20050113398A1 (en) * 2003-08-07 2005-05-26 Ankush Argade 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
CA2542096A1 (en) * 2003-10-09 2005-04-21 Aton Pharma, Inc. Thiophene and benzothiophene hydroxamic acid derivatives
CA2553848A1 (en) * 2004-01-21 2005-08-04 Cornell Research Foundation, Inc. Chemical inhibitors of soluble adenylyl cyclase (sac)
JP5319113B2 (ja) * 2004-03-26 2013-10-16 メチルジーン インコーポレイテッド ヒストンデアセチラーゼの阻害剤
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
EP1888058B1 (en) 2009-05-20
NO20080104L (no) 2008-03-03
JP2008542422A (ja) 2008-11-27
AR054378A1 (es) 2007-06-20
PE20061488A1 (es) 2007-02-03
TW200716090A (en) 2007-05-01
WO2006131398A2 (en) 2006-12-14
DE602006006908D1 (de) 2009-07-02
DE102005027274A1 (de) 2006-12-14
AU2006256857A1 (en) 2006-12-14
EP1888058A2 (en) 2008-02-20
CA2606692A1 (en) 2006-12-14
MX2007015493A (es) 2008-02-22
GT200600244A (es) 2007-01-23
WO2006131398A3 (en) 2007-04-19
KR20080016617A (ko) 2008-02-21
UY29583A1 (es) 2007-01-31
DOP2006000130A (es) 2006-11-30
ATE431736T1 (de) 2009-06-15
BRPI0610934A2 (pt) 2010-08-03
CN101193631A (zh) 2008-06-04
ZA200800153B (en) 2009-03-25
IL186914A0 (en) 2008-02-09
CR9578A (es) 2008-03-06
EA200702590A1 (ru) 2008-06-30

Similar Documents

Publication Publication Date Title
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
ECSP109922A (es) Compuestos de pirazol y su uso como inhibidores raf
NO20090295L (no) Substituerte heteroarylderivater
EA201790678A1 (ru) Бициклические гетероарильные соединения
CR11861A (es) Compuestos organicos
BR122013025375B8 (pt) compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas
MY153921A (en) Aminopyrazole derivatives
EA201000614A1 (ru) Производные пурина как лиганды аденозинового рецептора а
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
EA201170703A1 (ru) Производные адамантилбензамида
MX341849B (es) Nitrilos espirociclicos como inhibidores de proteasa.
EA200870515A1 (ru) Моноциклические гетероарильные соединения
BRPI0513149A (pt) uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito
NO20081207L (no) Isoquinolines as IGF-1R inhibitors
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CR9058A (es) Derivados de indol como inhibidores de la adenilato ciclasa soluble
UY30801A1 (es) Compuestos calciliticos
ATE445593T1 (de) Acetylenderivate
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
ECSP078024A (es) Inhibidores de la adenilato ciclasa soluble
DE602007005387D1 (de) Ptors
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
UY30235A1 (es) Inhibidores de la adenilato ciclasa soluble